Intellectus Partners, LLC Kiromic Biopharma, Inc. Transaction History

Intellectus Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.53 - $3.12 $151,240 - $308,412	-98,850 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$2.69 - $4.94 $64,425 - $118,313	23,950 Added 31.98%	98,850 $303,000
Q2 2021 Aug 13, 2021	BUY	$4.81 - $10.34 $176,767 - $379,995	36,750 Added 96.33%	74,900 $360,000
Q1 2021 May 17, 2021	BUY	$8.2 - $11.81 $23,779 - $34,249	2,900 Added 8.23%	38,150 $359,000
Q4 2020 Feb 18, 2021	BUY	$8.11 - $11.5 $280,232 - $397,371	34,554 Added 4964.66%	35,250 $299,000
Q4 2020 Feb 12, 2021	BUY	$8.11 - $11.5 $5,644 - $8,004	696 New	696 $299,000

107K

Ticker KRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,843,200
Market Cap $22.2M
Description
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate tar...

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Intellectus Partners, LLC with notifications on news.